Delphi EU and Competition Blog


Sweden’s first FDI fine for failed notification upheld: key takeaways

In a recent ruling, the Administrative Court in Stockholm upheld the decision by the Inspectorate of Strategic Products (the “ISP”) to impose a fine of SEK 200 000 (approx. EUR 20 000) on Ramsbury Invest AB for failing to notify an investment in due time. This marks the first court decision concerni...

Läs mer


One year with the Swedish FDI-regime

1 December 2024, marks one year since the Swedish Screening of Foreign Direct Investments Act (the ”FDI Act”) entered into force. As per 29 November 2024, 1,206 investments have been notified under the Swedish regime. In this blog post we will comment on the application of the FDI Act and provide st...

Läs mer


The future of EU merger control in the aftermath of Illumina/Grail

In Illumina/Grail the Court of Justice of the European Union (the “CJEU”) attempts to restore order to EU merger control, barring the Commission from using the EU Merger Regulation to extend its review powers. It remains to be seen whether this aim will be achieved. In this blog post we clarify Arti...

Läs mer



Expanded scope of the Swedish FDI Act

On 1 August 2024, the Swedish Civil Contingencies Agency (Sw. Myndigheten för samhällsskydd och beredskap) published its revised guidelines (MSBFS 2024:8) listing types of essential services that fall under the scope of the Swedish Act on Foreign Direct Investments (the “FDI Act”). The revised guide...

Läs mer




The Commission and National Competition Authorities Continue their Scrutiny of the Pharma Sector – the Commission’s Report Regarding the Enforcement in 2018-2022 just Published

On 26 January 2024, the European Commission (the “Commission”) published a report, providing an overview of the enforcement of the EU competition rules by the Commission and the National Competition Authorities (“NCA”) in the pharmaceutical sector during the period 2018 – 2022. The scrutiny of...

Läs mer